Advisornet Financial’s Anixa Biosciences ANIX Stock Holding History

Advisornet Financial’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-400	Closed	-$1K	–	1715
2020 Q2	$1K	Buy	+400	New	+$829	﹤0.01%	1641

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAS

Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Advisornet Financial's ANIX Position: Q3 2020 in Review

Advisornet Financial sold out of Anixa Biosciences (ANIX) in Q3 2020, closing a stake of 400 shares — an estimated $1K sold.

Advisornet Financial first reported a position in ANIX in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 21 funds tracked by Wall St. Rank hold ANIX as of Q3 2020.

Advisornet Financial reported no remaining Anixa Biosciences position as of Q3 2020 after selling out during the quarter.
Advisornet Financial sold 400 Anixa Biosciences shares in Q3 2020, an estimated $1K.
Advisornet Financial first reported a position in Anixa Biosciences in Q2 2020 and held it in 1 quarter.
Advisornet Financial's Anixa Biosciences position peaked at $1K in Q2 2020.
21 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2020.

Based on Advisornet Financial's 13F filing for Q3 2020, filed 6 Nov 2020.